The opinion rejects granting conditional marketing authorization to AB Science’s masitinib as an oral add-on treatment for ALS in the EU.

The first patient has been dosed in an open-label Phase 1/2 clinical trial of AMT-162, uniQure's one-time gene therapy for ...

The ALS Network – Your connection to care, research, and advocacy. We connect need with support, questions with answers, thought leaders with new ideas, research to funding, and advocates to challenge ...

After her late husband's diagnosis anniversary, columnist Juliet Taylor reflects on how grief became a heavy burden and a ...

Rozebalamin, an ultra-high dose vitamin B12 treatment, was approved in Japan to slow disease progression in people with ALS.

The Scott-Morgan Foundation is launching a joint initiative that aims to use AI technologies to help improve communication ...

People with ALS can benefit from voice-generating artificial intelligence, improving their quality of life, columnist Kristin Neva writes.

Muscular Dystrophy Association (MDA) is the #1 voluntary health organization in the United States for people living with muscular dystrophy, ALS, and over 300 related neuromuscular conditions.

A Texas Children’s Hospital investigator won a $2.4 million NIH grant for ALS and other neurodegenerative disease research.